Why buy Aurobindo Pharma shares

Aurobindo has seen strong revenue growth of 12% CAGR over the past five years thanks to rapid deposits in the United States, acquisitions in Europe and growth in other geographies. Aurobindo is expected to achieve stable growth from its traditional base in generics and also move up the value chain …

Read More »